UPDATED: After millions of Covid vaccine doses were botched, the feds hand control of a troubled Emergent Bio facility to J&J
Emergent BioSolutions has lost control of one of the principal US plants designated to make Covid-19 vaccines.
After mixing up vaccines from AstraZeneca and J&J, botching up to 15 million doses, J&J is now moving in its own manufacturing team — at the direction of the feds — to run Emergent’s troubled Bayview plant in Baltimore, which has been tagged for multiple operating violations.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 107,000+ biopharma pros reading Endpoints daily — and it's free.